Plastic Surgery Intelligence Briefing
Robotic 3D bioprinter skin in situ, BREAST-II trial for fat-only breast reconstruction, novel monopolar RF RCT, AI mapping across five surgical domains.
Weekly Intelligence Briefing
Peer-reviewed research, new surgical techniques, regenerative medicine, aesthetic devices, and significant innovations — curated weekly for plastic and reconstructive surgeons.
This week’s literature spotlights a randomized clinical trial suggesting copper-oxide dressings can be noninferior to NPWT for diabetic wounds (with major convenience and cost advantages), plus a new MMP-9–responsive hydrogel that releases M2 macrophage exosomes to accelerate diabetic wound healing. On the reconstruction side, early real-world experience with the Symani robotic microsurgery platform highlights where robotics may add the most value today—supermicrosurgery under 0.8 mm.
Read this issueThis Issue
Robotic 3D bioprinter skin in situ, BREAST-II trial for fat-only breast reconstruction, novel monopolar RF RCT, AI mapping across five surgical domains.
This week’s briefing spotlights new momentum in functional reconstruction (free-flap neurotization) and implant surveillance (a validated histologic method to q...
This week’s briefing highlights a novel extension of hemostatic-net quilting sutures for post–massive weight loss contouring, plus interim RCT data showing comp...
This week: the world's first living bioprinted ear cartilage implant advances to human trials, high-frequency ultrasound guidance lifts facial fat grafting sati...
Robotic microsurgery reaches a new milestone as the Synaptix+Symani digital overlay system demonstrates successful microvascular anastomosis in a pilot study, w...
This week’s literature highlights three converging themes: exosome-enabled wound therapeutics (smart, responsive hydrogels), renewed focus on post-op wound opti...
This week’s literature spotlights a randomized clinical trial suggesting copper-oxide dressings can be noninferior to NPWT for diabetic wounds (with major conve...